Quantcast

Latest Head and neck cancer Stories

2014-04-07 08:29:57

PRINCETON, N.J., April 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Dental and Craniofacial Research (NIDCR) has awarded Soligenix a Small Business Innovation Research (SBIR) grant...

2014-04-03 11:16:23

A team led by a scientist from the Florida campus of The Scripps Research Institute (TSRI) has identified a new biomarker linked to better outcomes of patients with head and neck cancers and non-small cell lung cancer. The work could help scientists develop new diagnostics and therapies and help physicians determine the best long-term treatments for patients with these cancers. The findings, which were published this week online ahead of print by the journal Cancer, focus on a protein...

2014-03-31 08:28:25

Organization forms alliance of dental professional organizations to boost public awareness through screening events NEWPORT BEACH, Calif., March 31, 2014 /PRNewswire/ -- April 1 kicks off the start of Oral Cancer Awareness Month. For the 15(th) year in a row, the Oral Cancer Foundation (OCF) is leading a national awareness effort by encouraging dental practices across the United States to offer free oral cancer screenings to people in their communities during the month of April. Through this...

2014-03-20 20:21:55

MARKHAM, ON, March 20, 2014 /PRNewswire/ - A Markham, Ontario-based company has developed a specialized test which screens for nasopharyngeal cancer. (Photo: http://photos.prnewswire.com/prnh/20140320/TO592) Nasopharyngeal cancer, known as NPC, is a rare but deadly disease. It is global in scope, and individuals with a Hong Kong, Southeast Asian, Inuit, North African, or Middle Eastern background have a higher risk for NPC. These individuals may benefit from this early...

2014-03-20 16:26:44

Public Can Get Free Screenings During Oral Head and Neck Cancer Awareness Week®, April 20-26 NEW YORK, March 20, 2014 /PRNewswire/ -- A first-of-its-kind study shows that sore throat and neck mass are the most common initial symptoms of a form of oral, head and neck cancer that is rapidly increasing in incidence, oropharyngeal squamous cell carcinoma (OPSCC). The study, published online March 20, 2014 in JAMA Otolaryngology - Head & Neck Surgery, cites sore throat as the most...

2014-03-05 16:26:22

Acclaimed surgical oncologist Carol Bier-Laning, MD, FASC, joins CTCA to lead comprehensive program for the treatment of head and neck cancer to offer surgical options for ear, nose and throat cancers CHICAGO, March 5, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) has launched a comprehensive head and neck cancer program to serve patients with cancers of the oral cavity, throat, larynx, nasal cavity,...

2014-02-20 08:32:02

Data Support Ongoing Randomized Phase 2 Study in Recurrent or Metastatic Head and Neck Cancer SEATTLE, Feb. 20, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc. announced today the presentation of clinical data of VTX-2337, a cancer immunotherapy, in combination with cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck cancer (SCCHN) at the 2014 Multidisciplinary Head and Neck Cancer Symposia in Scottsdale, Arizona. Results indicate that the...

2014-02-18 08:31:32

Met Primary Endpoint of Statistically Significant Reduction in Mouth and Throat Soreness Associated With Oral Mucositis; MuGard Patients Also Had Decreased Severity of Oral Mucositis by WHO Score NEW YORK, Feb. 18, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced the online early publication of the final results of its post-approval marketing study of MuGard(®) in Cancer, the journal of the American Cancer Society and one of the oldest peer-reviewed journals...

2014-01-08 12:29:02

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MarketVIEW: HPV therapeutic vaccinesHuman papilloma viruses (HPV) members of the papillomaviridae family are extremely common with an estimated worldwide prevalence of ~11-12%. Although nearly all sexually-active men and women acquire the virus at some point in their lives, most infections are asymptomatic and self-limiting; with 90% clearing within 2 years. High risk forms of HPV (16/18)...

2013-12-27 10:36:56

Patients with tongue cancer who started their treatment with a course of chemotherapy fared significantly worse than patients who received surgery first, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. This is contrary to protocols for larynx cancer, in which a single dose of chemotherapy helps determine which patients fare better with chemotherapy and radiation and which patients should elect for surgery. In larynx cancer, this...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related